Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

NCT00849797 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Teva Pharmaceuticals USA